<p>The current disclosure relates to high-affinity antibodies to EphA3 that have reduced immunogenicity when administered to a human to treat diseases and method of using such antibodies.</p>
申请公布号
AU2010313621(A1)
申请公布日期
2012.05.03
申请号
AU20100313621
申请日期
2010.10.14
申请人
KALOBIOS PHARMACEUTICALS, INC.
发明人
LUEHRSEN, KENNETH;MARTINEZ, DAVID;YI, CHRISTINA;BEBBINGTON, CHRISTOPHER R.;YARRANTON, GEOFFREY T.
